AstraZeneca said Friday it plans to apply for regulatory approval of an antibody cocktail that a preliminary study showed was highly effective in preventing symptomatic COVID-19, offering a potential alternative or complement to vaccines. The Anglo-Swedish drugmaker announced in an Aug. 20 release that the drug, a combination of two long-acting antibodies derived from convalescent…
AstraZeneca Antibody Cocktail 77 Percent Effective Against Symptomatic COVID-19 in Trial
August 20, 2021
admin
antibody cocktailAstrazenecaCCP ViruseffectiveHealth NewsMind & BodyPUBLIC HEALTH INFORMATIONTechVaccines & SafetyWorld
0 Comment
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta